All Stories

  1. Automatic Speech Classifier for Mild Cognitive Impairment and Early Dementia
  2. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
  3. CDKL5 knockout leads to altered inhibitory transmission in the cerebellum of adult mice
  4. Should we screen for cognitive decline and dementia?
  5. In vitro differentiation of porcine aortic vascular precursor cells to endothelial and vascular smooth muscle cells
  6. Role of the Thyroid System in Myelination and Neural Connectivity
  7. In vitro exposure to very low-level laser modifies expression level of extracellular matrix protein RNAs and mitochondria dynamics in mouse embryonic fibroblasts
  8. Radio Electric Asymmetric Conveyer: A Novel Neuromodulation Technology in Alzheimer’s and Other Neurodegenerative Diseases
  9. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling
  10. RELATIONSHIP BETWEEN CEREBROSPINAL FLUID (CSF) BIOMARKERS AND COGNITIVE PERFORMANCE OF PATIENTS WITH MILD COGNITIVE IMPAIRMENT (MCI) AFTER LONG-TERM TREATMENT WITH CHF5074
  11. Pharmacological targeting of the β-amyloid precursor protein intracellular domain
  12. Alzheimer's Disease: Discussing the “Bench-to-Bed” and the “Bed-to-Bench” Pathway Linking Preclinical and Clinical Research
  13. Cover Picture: Plasma Process. Polym. 3∕2014
  14. Carboxyl Surface Functionalization of Poly(L -lactic acid) Electrospun Nanofibers through Atmospheric Non-Thermal Plasma Affects Fibroblast Morphology
  15. Azetidinone–retinoid hybrids: Synthesis and differentiative effects
  16. Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats
  17. CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
  18. From the Multifactorial Nature of Alzheimer`s Disease to Multitarget Therapy: The Contribution of the Translational Approach
  19. Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074
  20. Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome
  21. Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?
  22. CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice
  23. Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
  24. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice
  25. Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome
  26. In vivo and in vitro study on microglia activation of CHF5074, a nonsteroidal anti-inflammatory derivative with gamma-secretase modulatory activity
  27. Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis
  28. Brain distribution of ribavirin after intranasal administration
  29. Biochips for Regenerative Medicine: Real-time Stem Cell Continuous Monitoring as Inferred by High-Throughput Gene Analysis
  30. Targeting of multiple metabolites in neural cells monitored by using protein-based carbon nanotubes
  31. Chronic administration of CHF5074, a novel γ-secretase modulator, prevents brain neurodegeneration in aged Alzheimer's disease transgenic mice
  32. Safety and pharmacokinetics of CHF5074, a novel gamma-secretase modulator, after multiple oral administrations to healthy humans
  33. Ultra-low-level laser therapy
  34. Carbon nanotubes-based electrochemical sensing for cell culture monitoring
  35. Chronic administration of CHF5074, a novel gamma-secretase modulator, dose-dependently restores object recognition memory in aged Alzheimer's disease transgenic mice
  36. Safety and pharmacokinetics of CHF5074, a novel gamma-secretase modulator, after single oral administration to healthy humans
  37. Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis
  38. Gabapentin treatment improves motor coordination in a mice model of progressive ataxia
  39. Effect of radiofrequency electromagnetic field exposure on in vitro models of neurodegenerative disease
  40. Acute administration of CHF5074, a novel gamma-secretase modulator, improves contextual memory in a transgenic mouse model of Alzheimer's disease
  41. Continuous exposure to 900MHz GSM-modulated EMF alters morphological maturation of neural cells
  42. Low infra red laser light irradiation on cultured neural cells: effects on mitochondria and cell viability after oxidative stress
  43. Neuropeptides and Receptors in Glia
  44. P3-299: Galanin and its agonist AR-M1896 protects the SN56 cholinergic cell line against beta amyloid 25-35 toxicity
  45. Prenatal glucocorticoid exposure affects learning and vulnerability of cholinergic neurons
  46. A molecular study of hippocampus in dogs with convulsion during canine distemper virus encephalitis
  47. The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells
  48. Cognitive impairment and cholinergic vulnerability in the rat model for multiple sclerosis
  49. Distribution of galanin in the brain of a galanin-overexpressing transgenic mouse
  50. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease
  51. Distribution of galanin and galanin transcript in the brain of a galanin-overexpressing transgenic mouse
  52. Neuroprotection: A Realistic Goal for Aged Brain?
  53. Stem cells and nervous tissue repair: from in vitro to in vivo
  54. ‘Neuro’-peptides in glia: Focus on NPY and galanin
  55. [1-13C]Glucose entry in neuronal and astrocytic intermediary metabolism of aged rats
  56. Plasticity of GABA(a) system during ageing: focus on vestibular compensation and possible pharmacological intervention
  57. Thyroid hormone and retinoids affect motoneuron phenotype and reaction after axotomy in the spinal cord of adult rats
  58. Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex
  59. Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex
  60. Long-Lasting Regulation of Galanin, Opioid, and Other Peptides in Dorsal Root Ganglia and Spinal Cord during Experimental Polyarthritis
  61. Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor
  62. Is neuronal nitric oxide involved in adjuvant-induced joint inflammation?
  63. Thyroid Hormone-Dependent Regulation of Galanin Synthesis in Neurons and Glial Cells after Colchicine Administration
  64. NGF content and expression in the rat pituitary gland and regulation by thyroid hormone
  65. Sexual impotence is associated with a reduced production of oxytocin and with an increased production of opioid peptides in the paraventricular nucleus of male rats
  66. Effect of chronic clozapine administration on [3H]MK801-binding sites in the rat brain: a side-preference action in cortical areas
  67. Regulation of glutamic acid decarboxylase mRNA expression in rat brain after sertraline treatment
  68. Age-related changes in the expression of corticotropin-releasing hormone receptor mRNA in the rat pituitary
  69. Nitric oxide is involved in male sexual behavior of rats
  70. Italian professorships
  71. Reforming Italy's academic appointments system
  72. Regulation of VIP mRNA expression by thyroid hormone in different brain areas of adult rat
  73. Autoradiographic Detection of Substance P Receptors in Normal and Psoriatic Skin
  74. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress
  75. Response of Hypothalamic Peptide mRNAs to Thyroidectomy
  76. Deficit of Galanin-Like Immunostaining in the Median Eminence of Adult Hypothyroid Rats
  77. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid levels during pregnancy
  78. Regulation of NT Receptors after Chronic Treatment with Typical and Atypical Neuroleptic Drugs
  79. DA2/NT receptor balance in the mesostriatal and mesolimbocortical systems after chronic treatment with typical and atypical neuroleptic drugs
  80. Presence and Synthesis of Inhibin Subunits in Human Decidua*
  81. Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat
  82. Increase of neuropeptide Y-like immunoreactivity in the paraventricular nucleus of fasting rats
  83. Behavioral and neurochemical modifications induced by apomorphine treatment
  84. Identification of Immunoreactive Neuropeptide-γ in Human Placenta: Localization, Secretion, and Binding Sites*
  85. Daily Modifications of 3h-Naloxone Binding Sites in the Rat Brain: A Quantitative Autoradiographic Study
  86. Presence of 5-HT-positive neurons in the medial nuclei of the solitary tract
  87. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides
  88. Effects of Chronic GM1 Ganglioside Treatment on Nigral Dopamine Cell Bodies and Dendrites in Experimental Rats Using Image Analysis — Relationship to the Pharmacokinetic Properties
  89. Morphometrical and Microdensitometrical Studies on Monoaminergic and Peptidergic Neurons in the Aging Brain
  90. Effects of Chronic GM1 Ganglioside Treatment on Nigral Dopamine Cell Bodies and Dendrites in Experimental Rats Using Image Analysis — Relationship to the Pharmacokinetic Properties
  91. Morphometrical and Microdensitometrical Studies on Monoaminergic and Peptidergic Neurons in the Aging Brain
  92. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat
  93. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting*
  94. Chronic treatment with I-dopa plus carbidopa in hemitransected rats: Preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity
  95. Intracisternal administration of avian pancreatic polypeptide lowers respiration rate and enhances the clonidine induced reduction of respiration rate in α-chloralose anesthetized rats: Possible interactions with an α2-adrenergic receptor
  96. Evidence for stabilization of cortical 5HT neurotransmission by chronic treatment with antidepressant drugs: induction of a high and a low affinity component in 3H-5HT binding sites